Heart Matters cover art

All Episodes

Heart Matters — 226 episodes

#
Title
1

Anticoagulation Reversal Decisions in Cardiothoracic Surgery: Case-Based Insights

2

Navigating ASCVD and Pancreatitis Risk in Severe Hypertriglyceridemia

3

Updated AACE Guidance on Managing Dyslipidemia in T2D

4

Applying Guideline Recommendations to ACS Management

5

Overcoming Challenges in ATTR-CM Diagnosis

6

Multidisciplinary Care in ATTR-CM: Building the Right Team

7

Building Clinical Expertise in ATTR-CM Management

8

The Future of ATTR-CM Care: A Look at What's Next

9

Managing Acute PE: Updates from the 2026 AHA/ACC Guideline

10

From Goals to Action: Multisociety Guidance on Lipid Management

11

Managing Dyslipidemia: 2026 ACC/AHA Guideline Updates

12

How PCSK9 Inhibition Lowers LDL Cholesterol

13

Enlicitide for LDL-C Management: Insights from CORALreef Lipids

14

Risk Prediction with the PREVENT-ASCVD Equations

15

The Patient You Might Be Missing: Severe Hypertriglyceridemia in Clinical Practice

16

Evaluating ASCVD Risk with the CPR Framework

17

Looking Ahead in ATTR-CM Care: Improving Diagnosis, Outcomes, and Equity

18

Hypertension in Women: Cardiovascular Risk Across the Lifespan

19

Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies

20

Diagnosing ATTR-CM: Recent Advances and Future Directions

21

When to Suspect ATTR-CM: Clues for Earlier Diagnosis

22

Understanding the Mechanisms Behind Resistant Hypertension

23

Quality of Life Conversations in ATTR-CM Care

24

Hypertension Across Diverse Populations: Practical Strategies for Equitable Care

25

Cardiometabolic Considerations in Familial Chylomicronemia Syndrome

26

Advances in Sports Cardiology: Updates from ACC 2026

27

Supporting Patients With ATTR-CM: Preserving Function and Quality of Life

28

Counseling Patients on Disease Progression in ATTR-CM

29

AI-Driven Advances in ATTR-CM Care

30

Redefining ATTR Treatment: Key Mechanisms and Emerging Data

31

Advances in ATTR-CM: Evolving Diagnostics and Therapeutics

32

Treating ATTR-CM Early: A Shift From Reactive to Strategic Care

33

Closing Gaps in ASCVD Prevention: Lipid Management Insights from AHA 2025

34

Rethinking Hormones: Testosterone and Estrogen in Women’s Heart Health

35

Targeting Vascular KCNQ5 Channels: A Promising Strategy for Blood Pressure Control

36

Navigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control

37

Understanding Lipid and Lipoprotein Metabolism in Cardiovascular Health

38

Sex-Based Differences in Lipid Management: Implications for Cardiovascular Risk

39

Gender Bias and Heart Health: Improving Cardiovascular Care for Women

40

Managing Cholesterol and Triglyceride Levels: Targeted Nutritional Approaches

41

Managing Statin Intolerance: Practical Approaches and Emerging Non-Statin Options

42

Improving Lipid Management Through Equity-Focused Clinical Strategies

43

Optimizing Cardiovascular Outcomes in Hyperlipidemia Through Risk-Based Care

44

How Artificial Sweeteners Could Be Linked to Heart Disease

45

Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link

46

Active Aging: Preventing Heart Failure in Older Women with Exercise

47

AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD

48

Pharmacist-Prescribing and Hypertension Management: An Economic Benefit

49

Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity

50

A Discussion on Statins to Lower CVD Risk for HIV Patients

51

A Discussion on the Updated Recommendations for Managing Dyslipidemia in Adults

52

Identifying Cardiovascular Risk Factors for HIV Patients

53

Exploring Emerging Non-Statin LDL Lowering Therapies

54

Assessing the Effectiveness of Lp(a) Lowering Therapies in Clinical Trials

55

Stanford Surgeons Perform First Beating-Heart Procedure

56

Treating Tricuspid Valve Regurgitation With Novel Replacement Device

57

Exploring the Use of AI to Detect HFpEF

58

Updates from ACC 2023: Examining Transcatheter Repair Study Data

59

Cardio-Oncology: Key Clinical Data from ACC.23

60

The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team

61

The STELLAR Trial: Key Data on Sotatercept for PAH

62

A Look at Lipoprotein(a): Key Screening & Treatment Strategies

63

Anticipated Updates on Statin Intolerance at ACC 2023

64

The Role of Implementation Science in Familial Hypercholesterolemia

65

Updated Guidelines for Youth With Dyslipidemia

66

A Look into the Effectiveness of Dietary Supplements

67

Uncovering the Results of the DELIVER Trial

68

Exploring Novel Tools for PAH: Measuring Severity with a New Blood Test

69

Investigating the Link Between PCOS & CV Risk Factors During Delivery

70

When Climate & Cardiology Overlap: How Climate Change Can Impact Heart Health

71

The miniPUMP: A New Way to Get a Close-Up View of the Heart

72

Improving Adherence Among HF Patients: A Look at the PROMPT-HF Trial

73

What the SODIUM-HF Trial Means for Heart Failure Patients

74

Breaking Down the Criteria for Iron Deficiency in Heart Failure

75

Reviewing the Role of SGLT2 Inhibitors in Heart Failure

76

Looking into Long-Term Cardiovascular Impacts of COVID-19

77

Cardio-Obstetrics: Taking Better Care of Our Pregnant & Postpartum Patients

78

Exploring Xenotransplantation: Is the Future of Heart Transplants Now?

79

One Foundation's Approach to Preventing Sudden Cardiac Death in Young Athletes

80

Ejection Fraction in Heart Failure: Does It Matter?

81

Cardiac Rehabilitation: Key Considerations for Breast Cancer Survivors

82

Diving into Diversity: A Look at Representation in Cardiovascular Clinical Trials

83

Patching Up Cardiovascular Risk

84

Coronary Heart Disease & Postmenopausal Women: Evaluating Risk Through Research

85

Considering Cannabis & the Cardiovascular System: A Look at Patient Outcomes

86

Exploring the Careers of Cardiologists: A Noninvasive Cardiologist's Journey & a First-Year Student's Story

87

Examining Coronary Heart Disease & Psychosocial Stressors

88

Cardiovascular Complications & Pregnancy: What Cardiologists Need to Know

89

How Can Space Travel Affect Our Heart Health?

90

Investigating the Relationship Between Pregnancy Complications & Coronary Disease

91

ASCVD Risk & Women: Investigating Impact on Female Patients

92

Spotlighting Excellence in Cardiology Care Amid the COVID-19 Pandemic

93

An Epidemic Amid a Pandemic: CVD, COVID-19, & the Leading Cause of Death Worldwide

94

Addressing Racial Disparities in Cardiovascular Care

95

Clinical Cardiovascular Care: Antiplatelet & Anticoagulation Strategies

96

Exploring Strategies to Eliminate Disparities in Cardiovascular Care

97

Exploring the Effect of Triglycerides

98

Cardiology Care Amid the COVID-19 Pandemic: Remote-Monitoring Technologies

99

Evaluating Essential Strategies for Reducing the Risk of Cardiovascular Disease

100

Exploring the Prevalence of Congenital Heart Disease in Conjoined Twins

101

Detecting & Diagnosing Diabetes in Cardiology Patients

102

Cardiology Among the Constellations: Exploring Microgravity & Space Flight

103

Assessing Advancements in Preventative Cardiology

104

Evaluating the Updated ACC/AHA Cholesterol Guidelines

105

Showcasing a Hero in Cardiology Care: Dr. Heval Kelli

106

Assessing Advancements in Cardiology: Women & Heart Disease

107

Gazing into the Cardiology Crystal Ball: The Future of Preventive Care

108

At the Heart of Healthcare: Addressing the Future of Cardiology Care

109

Exploring Female Underrepresentation in Heart Failure Research

110

Understanding the Link Between Utero Diabetes & Heart Disease in Young Adults

111

Uncovering Evidence on Blood Pressure Improvements in Americans

112

Sci-Fi in the OR: Utilizing Holograms in Cardiac Ablation Procedures

113

Finding the Answer to How & Why Arteries Age

114

How Does COVID-19 Affect the Heart?

115

Revising CPR to Improve Cardiac Arrest Outcomes Outside the Hospital

116

Identifying Unstable Coronary Plaques

117

Examining Links Between Vitamin D Deficiency and Cardiovascular Disease

118

Genetic Testing for Long QT Syndrome

119

Simple Screening for Older Patients Considering Cardiac Surgery

120

The Obesity Epidemic in Mississippi: A Mirror for the Nation

121

Part 2: A Plant-Based Diet for Preventing and Possibly Reversing Coronary Artery Disease

122

Could Silkworms Help Repair Clogged Arteries?

123

When More Isn't Better: Questioning the Efficacy of Common Cardiovascular Treatments

124

How to Develop Interdisciplinary, Realistic Health Policies in an Era of Health System Reform

125

Does the Entire Healthcare System Need a Redesign?

126

The Complexity of Medication Management for Older Patients with Heart Failure

127

Evaluation of Second Generation Drug-Eluting Stents

128

Part 1: A Plant-Based Diet for Preventing and Possibly Reversing Coronary Artery Disease

129

Faster Treatment of MI with the Help of Wireless EKG Programs

130

PPIs and Antiplatelet Therapy: Weighing the Benefits and Risks

131

Fortilin and Targeted Molecular Therapy for Preventing Atherosclerosis

132

Should We Screen Asymptomatic Patients for Subclinical Atherosclerosis?

133

Methods to Identify Quality in Cardiovascular Practices

134

From Haiti to the US: Public-Private Partnerships in Healthcare

135

Anticoagulation Therapies for Atrial Fibrillation

136

Genetic Clues to Heart Health

137

Comparative-Effectiveness Research on Implantable Cardioverter Defibrillators

138

The 50th Anniversary of the First Prosthetic Heart Valve

139

Expanding the Anti-Arrhythmia Armamentarium: Where Does Dronedarone Fit In?

140

Should We Add ECG to Routine Screening of Young Athletes?

141

Linking Air Pollution and Heart Disease

142

All Things in Moderation: Small Lifestyle Changes for Cardiovascular Health

143

The Clinically Broken Heart: Stress-Induced Cardiomyopathy

144

Catheter Ablation Therapy for Atrial Fibrillation

145

The Road Less Traveled: Recognizing Comorbidities and Non-Traditional Characteristics in Patients With Heart Failure

146

The Myths and Realities of Myocardial Infarction Prevention With Vaccination

147

Doctor as Patient Advocate: Top Tools to Empower Your Patients

148

Modernizing the FDA Premarket Approval Process for Medical Devices

149

The Heart and the Lungs: Linking COPD and Cardiac Output

150

Healthcare Cost Containment and Medical Liability Reform

151

Global Disparities in Arrhythmia Management

152

A Global Issue: Obesity and Improving Cardiovascular Health in Children

153

Heart Disease in Ancient Egyptians

154

Deciphering Meaningful Use of Health Information Technology

155

The Value and Future of the Maintenance of Certification Program

156

Health Reform and Cardiology in the Year Ahead

157

The Future of Medical Device Innovation

158

The Patient-Centered Medical Home: New Delivery Models and Healthcare Reform

159

The Rapid Evolution of Ventricular Assist Devices

160

Transforming the Standard of Care for Acute Coronary Syndromes

161

Glucose Control After Acute Myocardial Infarction

162

Can Autologous Stem Cells Reverse the Damage of a Heart Attack?

163

Future Cardiovascular Disease & the Big Impact of Small Salt Reductions

164

Surpassing the Clipboard: Integrating HIT Into Your Practice

165

Preparing for Medicare Payment Cuts

166

As Prescribed: Meeting the Challenges of Medication Adherence

167

Cardiac Care on Ice: Therapeutic Hypothermia for Cardiac Arrest

168

The Spectrum of Treatment for Left Ventricular Dysfunction

169

When to Screen for Fibromuscular Dysplasia

170

Targeting Anemia, Iron Deficiency for Patients With Heart Failure

171

The Challenges of Defibrillator and Pacemaker Lead Extraction

172

The ARBITER 6-HALTS Trial: Clinical Implications

173

The Advantages of a Collaborative Cardiac Care Model

174

Troponin Assays for Diagnosing Myocardial Infarction

175

New Recommendations for STEMI and PCI

176

The Role of Cardiac Resynchronization in the Prevention of Heart Failure

177

The Hypertension Paradox: Better Treatment, Worse Outcomes

178

Pediatric Heart Disease: The Need for More Rigorous Clinical Evidence

179

When Patients Leave the Hospital, a Healthier Transition

180

My Heart Your Heart: Explanting Pacemakers to Reuse Abroad

181

The Scientific Pursuit of More Precise Care

182

Endoscopic Vein-Graft Harvesting in CABG Procedures

183

Walk for Cardiovascular Health: Programs Around the Country

184

The NCDR Family of Registries: What Clinicians Need to Know

185

Warranties, Integration and Enduring Innovation at Geisinger

186

The Possibility of Cardiac Cell Regeneration

187

Framingham: The Foundation of Modern Heart Research

188

Comparative Effectiveness Research: How to Get There?

189

Where Do Accountable Care Organizations Fit Into Reform?

190

How to Achieve, Measure, and Maintain Quality of Care

191

Cardiac Care for a Young, At-Risk Population in Saudi Arabia

192

National Health Reform and Lessons Learned From California

193

Going Home and Staying Home: Reducing Readmissions

194

Focused Factories: A Path to Reduce Cost and Boost Quality

195

Reducing Childhood Obesity, One Sound Policy at a Time

196

Forging a Path Toward Cardiac Applications for Stem Cells

197

How Close Are We to a Cardiac Polypill?

198

Contraceptive Hormones & CV Disease: Pursuing the Link

199

Stable Coronary Artery Disease: PCI Versus Medical Therapy

200

Women and Heart Disease: Closing the Outcomes Gap

201

The Right Test at the Right Time: Progress in Cardiac Imaging

202

Reforming the FDA's Drug Approval Process

203

The Year Ahead in Cardiology and Health Policy

204

Pre-Operative Cardiac Risk Assessment and Risk Reduction

205

Stroke Prevention in Patients with Atrial Fibrillation

206

With or Without Surgical Backup? Settling the Debate on PCI

207

The Role of Employers in the Health Reform Movement

208

Potential Concerns About the Newest Line of ICD Technology

209

Coronary CT Angiography: To Order or Not to Order?

210

The Cost-Benefit Calculus of CT Angiograms

211

Easing the Healthcare Burden on Small Businesses

212

Industry and Healthcare: Sorting Out Potential Conflicts

213

Treatment Guidelines: The Ongoing Pursuit of Excellence

214

Sudden Cardiac Death in Athletes

215

Examining the Biodegradable Stent

216

A More Definitive Ablation Procedure for Atrial Fibrillation

217

Antiplatelet Therapy After Drug-Eluting Stent Implantation

218

Advances in Managing Atrial Fibrillation

219

Recognizing the Subtle Signs of Aortic Valve Disease

220

Developments in Surgical Therapies for Valve Disease

221

Measures to Improve Quality and Physician Payments

222

Healthcare Reform: An Economist’s Perspective

223

Close a Hole in the Heart, Heal Pain in the Head?

224

Updating Guidelines for Unstable Angina and NSTEMI

225

Updating Guidelines for ST-Elevation MI

226

Hypertrophic Cardiomyopathy: Diagnosis and Treatment